EuropeSouth AsiaAsia PacificAmericasMiddle EastAfricaBBC HomepageWorld ServiceEducation
News image
News image
News image
News imageNews image
News image
Front Page
News image
World
News image
UK
News image
UK Politics
News image
Business
News image
Sci/Tech
News image
Health
News image
Education
News image
Sport
News image
Entertainment
News image
Talking Point
News image
News image
News image
On Air
Feedback
Low Graphics
Help
News imageNews imageNews image
News imageTuesday, September 1, 1998 Published at 13:09 GMT 14:09 UK
News image
News image
Health
News image
Diarrhoea vaccine could save millions of young lives
News image
Vaccine combats the leading cause of diarrhoea
News image
The world's first vaccine against the leading cause of childhood diarrhoea has been granted a licence in the US.

Diarrhoea caused by the intestinal infection rotavirus kills 1m children every year in developing countries, and puts millions of others into hospital.

The new vaccine, RotaShield, could save thousands of lives by combating the infection.

The drug is designed to be taken by children three times during the first year of life, at two months, four months, and six months.

The US Food and Drug Administration has warned that cost may prevent the vaccine's widespread use in developing countries.

Developing countries targeted

But manufacturer Wyeth-Ayerst Laboratories has pledged to get the vaccine to children in developing countries, probably by using profits from rich countries to subsidise poor ones.

Dr Albert Kapikian, who has worked on a vaccine for 24 years, said: "It's very exciting news. I think it's going to have a major impact."

Rotavirus is the leading cause of severe childhood diarrhoea, attacking the lining of the small intestine.

In severe cases, a child can experience 10 to 20 episodes of diarrhoea in a single day, quickly getting dangerously dehydrated.

Infects most children


[ image: Vaccine proved effective in Venezuelan study]
Vaccine proved effective in Venezuelan study
Dr Kapikian said rotavirus infected approximately 75% of all children before the age of five years.

One in 40 children is hospitalised, but good health care, especially replacing lost fluids, limits deaths.

In studies of US infants, RotaShield prevented between 70% and 90% of severe diarrhoea, although it did not eliminate rotavirus.

A study in Venezuela last year concluded the vaccine was equally effective in developing countries.

Professor John Calam, of the gastroenterology department at Hammersmith Hospital, London, said: "This sounds like a big breakthrough. However, it may be that the people who really need it - the six month old children in Bangladesh - cannot get it."

Side effects

The main side effects of the vaccine are low fevers, irritability and decreased appetite within five days of the first doses.

The FDA said it is safe to give RotaShield, an oral vaccine, at the same time as vaccines against polio, diphtheria, whooping cough, tetanus and a form of meningitis that infants also get by six months of age.

RotaShield is a live vaccine that protects against the four viral strains that cause 95 percent of the world's rotavirus cases.

News image


Advanced options | Search tips


News image
News image
News imageBack to top | BBC News Home | BBC Homepage |
News image

News imageNews imageNews image
Health Contents
News image
News imageBackground Briefings
News imageMedical notes
News imageRelevant Stories
News image
02 Aug 98�|�Health
Thousands risk diphtheria in jab scare
News image
29 Jul 98�|�Health
Immunising against worry
News image
10 Jun 98�|�Latest News
'Asthma vaccine close'
News image
01 Jun 98�|�Latest News
A vaccine for blood cancer?
News image

News image
News image
News image
News imageInternet Links
News image
Diarrhoea
News image
Rotavirus
News image
RotaShield
News image
News imageNews image
The BBC is not responsible for the content of external internet sites.

News image
News image
News image
News imageIn this section
News image
Disability in depth
News image
Spotlight: Bristol inquiry
News image
Antibiotics: A fading wonder
News image
Mental health: An overview
News image
Alternative medicine: A growth industry
News image
The meningitis files
News image
Long-term care: A special report
News image
Aids up close
News image
From cradle to grave
News image
NHS reforms: A guide
News image
NHS Performance 1999
News image
From Special Report
NHS in crisis: Special report
News image
British Medical Association conference '99
News image
Royal College of Nursing conference '99
News image

News image
News image
News image